Abstract
Several reports have suggested an association between chronic allopurinol ingestion and cortical and subcapsular cataract formation. To examine this possibility we identified 51 allopurinol users and compared their lenses with those of 76 patients who did not use allopurinol. The existence of lens opacities and the level of visual acuity were assessed by review of medical records or by prospective ophthalmic examinations; in both phases of the study the examiners were blinded as to the patient's use or non-use of allopurinol. Three different outcomes were considered: formation of any cataract, formation of a posterior subcapsular cataract, and formation of a cataract contributing to a corrected visual acuity of 20/30 or worse. The risk ratio for the formation of any cataract was 1.3 (95% confidence interval: 0.8, 2.0), the risk ratio for the formation of a posterior subcapsular cataract was 0.9 (0.3, 2.0), and the risk ratio for the formation of a cataract contributing to a loss of visual acuity was 1.3 (0.6, 2.9). None of these risk ratios was changed appreciably after controlling for age, sex, hypertension, or diabetes. Thus, after a mean of 6.9 years of allopurinol use, we found no evidence to confirm that allopurinol users were at higher risk of acquiring cataracts.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chylack L. T., Jr Classification of human cataracts. Arch Ophthalmol. 1978 May;96(5):888–892. doi: 10.1001/archopht.1978.03910050490021. [DOI] [PubMed] [Google Scholar]
- Chylack L. T., Jr, Lee M. R., Tung W. H., Cheng H. M. Classification of human senile cataractous changes by the American Cooperative Cataract Research Group (CCRG) method. I. Instrumentation and technique. Invest Ophthalmol Vis Sci. 1983 Apr;24(4):424–431. [PubMed] [Google Scholar]
- Chylack L. T., Jr, Ransil B. J., White O. Classification of human senile cataractous change by the American Cooperative Cataract Research Group (CCRG) method: III. The association of nuclear color (sclerosis) with extent of cataract formation, age, and visual acuity. Invest Ophthalmol Vis Sci. 1984 Feb;25(2):174–180. [PubMed] [Google Scholar]
- Chylack L. T., Jr, Rosner B., Garner W., Giblin F., Waldron W., Wolfe J., Leske M. C., White O. Validity and reproducibility of the Cooperative Cataract Research Group (CCRG) cataract classification system. Exp Eye Res. 1985 Jan;40(1):135–147. doi: 10.1016/0014-4835(85)90116-2. [DOI] [PubMed] [Google Scholar]
- Chylack L. T., Jr, White O., Tung W. H. Classification of human senile cataractous change by the American Cooperative Cataract Research Group (CCRG) method: II. Staged simplification of cataract classification. Invest Ophthalmol Vis Sci. 1984 Feb;25(2):166–173. [PubMed] [Google Scholar]
- Cotlier E., Sharma Y. R., Niven T., Brescia M. Distribution of salicylate in lens and intraocular fluids and its effect on cataract formation. Am J Med. 1983 Jun 14;74(6A):83–90. doi: 10.1016/0002-9343(83)90534-x. [DOI] [PubMed] [Google Scholar]
- Fraunfelder F. T., Hanna C., Dreis M. W., Cosgrove K. W., Jr Cataracts associated with allopurinol therapy. Am J Ophthalmol. 1982 Aug;94(2):137–140. doi: 10.1016/0002-9394(82)90067-8. [DOI] [PubMed] [Google Scholar]
- Jick H., Brandt D. E. Allopurinol and cataracts. Am J Ophthalmol. 1984 Sep 15;98(3):355–358. doi: 10.1016/0002-9394(84)90328-3. [DOI] [PubMed] [Google Scholar]
- Lerman S., Megaw J. M., Gardner K. Allopurinol therapy and cataractogenesis in humans. Am J Ophthalmol. 1982 Aug;94(2):141–146. doi: 10.1016/0002-9394(82)90068-x. [DOI] [PubMed] [Google Scholar]
- Lerman S., Megaw J., Fraunfelder F. T. Further studies on allopurinol therapy and human cataractogenesis. Am J Ophthalmol. 1984 Feb;97(2):205–209. doi: 10.1016/s0002-9394(14)76091-x. [DOI] [PubMed] [Google Scholar]